Anavex Life Sciences's total assets for Q1 2025 were $124.04M, a decrease of -8.50% from the previous quarter. AVXL total liabilities were $13.13M for the fiscal quarter, a -14.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.